⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1247300 | 0.97 | — | — | |
| SCHEMBL1184710 | 0.80 | — | — | |
| SCHEMBL1459586 | 0.78 | — | — | |
| SCHEMBL37987 | 0.76 | ALDH1A1 (1.00) | — | |
| SCHEMBL5351781 | 0.76 | ALDH1A1 (0.47) | — | |
| SCHEMBL4898326 | 0.76 | ALDH1A1 (0.47) | — | |
| SCHEMBL12515765 | 0.76 | ALDH1A1 (0.40) | — | |
| SCHEMBL12323560 | 0.74 | ALDH1A1 (0.39) | — | |
| SCHEMBL949685 | 0.72 | — | — | |
| Ammonia Solution, Strong SCHEMBL28802926 | 0.72 | ALDH1A1 (0.91) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 440 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112409131-A | Synthetic preparation method of 3-bromo-2, 2-dimethyl-1-propanol | 南京麦瑞米生物技术有限公司 | 2021-02-26 | — | — | CN | claimed |
| WO-2017207385-A1 | SUBSTITUTED 3-METHYLINDAZOLES, METHODS FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING SAME, AND USE THEREOF FOR THE PRODUCTION OF MEDICAMENTS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-12-07 | — | — | WO | claimed |
| EP-4743078-A2 | APOL1 INHIBITORS AND METHODS OF USE | Maze Therapeutics, Inc. (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-4737451-A1 | NOVEL CARBOXAMIDE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Dong Wha Pharm. Co., Ltd. (KR) | 2026-05-06 | — | — | EP | disclosed |
| US-12617802-B2 | Sulfonimidamide compounds as NLRP3 modulators | GENENTECH, INC. (US) | 2026-05-05 | — | — | US | disclosed |
| US-20260116881-A1 | KIF MODULATOR COMPOUNDS AND METHODS OF USE | IAMBIC THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4200015-B1 | SUBSTITUTED HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9 | BRISTOL MYERS SQUIBB CO (US) | 2026-04-29 | — | — | EP | disclosed |
| EP-4717695-A1 | CRYSTAL FORM AND SALT FORM OF FIVE- AND SIX-MEMBERED COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND USE | Hangzhou Polymed Biopharmaceuticals, Inc. (CN) | 2026-04-01 | — | — | EP | disclosed |
| US-20260085057-A1 | SUBSTITUTED INDAZOLES USEFUL FOR TREATMENT AND PREVENTION OF ALLERGIC AND/OR INFLAMMATORY DISEASES IN ANIMALS | Bayer Pharma AG (DE) | 2026-03-26 | — | — | US | disclosed |
| EP-4714952-A1 | COMPOUND AND USE THEREOF | Autobio Group Co., Ltd. (CN) | 2026-03-25 | — | — | EP | disclosed |
| US-12570625-B2 | 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof | NOVARTIS AG (CH) | 2026-03-10 | — | — | US | disclosed |
| US-5145846-A | Skin disorders, leukemia, sebaceous gland disorders | HOFFMANN-LA ROCHE INC. (US) | 1992-09-08 | — | — | US | disclosed |
| EP-0479871-A1 | NOVEL VITAMIN D ANALOGUES. | LEO PHARM PROD LTD (DK) | 1992-04-15 | — | — | EP | disclosed |
| EP-0325279-B1 | DEHYDROCHOLECALCIFEROL DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1992-04-01 | — | — | EP | disclosed |
| US-5087619-A | For treatment of skin or gland disorders; antitumor agents | HOFFMAN-LA ROCHE INC. (US) | 1992-02-11 | — | — | US | disclosed |
| WO-1991000271-A1 | NOVEL VITAMIN D ANALOGUES | Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) (DK) | 1991-01-10 | — | — | WO | disclosed |
| EP-0325279-A1 | Dehydrocholecalciferol derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1989-07-26 | — | — | EP | disclosed |
| US-4772433-A | Vitamin D analogues | RESEARCH INSTITUTE FOR MEDICINE AND CHEMISTRY INC. (US) | 1988-09-20 | — | — | US | disclosed |
| EP-0078704-B1 | INTERMEDIATES IN THE SYNTHESIS OF VITAMIN D DERIVATIVES | RESEARCH INSTITUTE FOR MEDICINE AND CHEMISTRY INC. (US) | 1987-04-29 | — | — | EP | disclosed |
| EP-0078704-A1 | Intermediates in the synthesis of vitamin D derivatives | RESEARCH INSTITUTE FOR MEDICINE AND CHEMISTRY INC. (US) | 1983-05-11 | — | — | EP | disclosed |